Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
Total compensation is similar to the industry average Collegium Pharmaceutical's EPS grew by 24% over the past three years while total shareholder return over the past three years was 74% The performance at Collegium Pharmaceutical, Inc. NASDAQ:COLL ) has been quite strong recently and CEO Joe Ciaffoni has played a role in it. Coming up to the next AGM on 16th of May, shareholders would be keeping this in mind. It is likely that the focus will be on company strategy going forward as shareholders hear from the board and cast their votes on resolutions such as executive remuneration and other matters. We think the CEO has done a pretty decent job and we discuss why the CEO compensation is appropriate. View our latest analysis for Collegium Pharmaceutical Comparing Collegium Pharmaceutical, Inc.'s CEO Compensation With The Industry Our data indicates that Collegium Pharmaceutical, Inc. has a market capitalization of US$1.2b, and total annual CEO compensation was reported as US
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- Collegium Announces $35 Million Accelerated Share Repurchase ProgramGlobeNewswire
- Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $39.00 price target on the stock.MarketBeat
- Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.MarketBeat
- Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet [Yahoo! Finance Canada]Yahoo! Finance Canada
- Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
COLL
Earnings
- 5/9/24 - Beat
COLL
Sec Filings
- 5/20/24 - Form 8-K
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- COLL's page on the SEC website